MV

Muddada Venugopal

Director Director DIN 06934223
DIN 06934223 First appointment Oct 2014 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Muddada Venugopal

Data last updated:

Muddada Venugopal was a Director at Dexter Formulation Private Limited (2014–2015) and Managing Director at Baymax Pharmalabs Private Limited (from 2015). The companies operate in Pharma.

DIN 06934223
Primary Designation Director
Industry Pharma
First Appointment 31 Oct 2014
Oldest Company Age 11 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dexter Formulation Private Limited U33110TN2009PTC071429
Director31 Oct 20142009₹1.18 Cr (FY 2025)Active
Baymax Pharmalabs Private Limited U74900TN2015PTC101372
Managing Director10 Jul 20152015Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Baymax Pharmalabs Private Limited
Dexter Formulation Private Limited
Premium access

Shareholding and investment profile for Muddada Venugopal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Muddada Venugopal

Muddada Venugopal was first appointed on 31 Oct 2014 as Director at Dexter Formulation Private Limited. The most recent appointment on record is 10 Jul 2015 at Baymax Pharmalabs Private Limited.

Muddada Venugopal held 2 earlier board appointments: Dexter Formulation Private Limited (Director, 31 Oct 2014 to 01 Oct 2015); Baymax Pharmalabs Private Limited (Managing Director, from 10 Jul 2015).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available